DE602007013772D1 - Behandlung mykobakterieller infektionen mit cyclipostinen - Google Patents

Behandlung mykobakterieller infektionen mit cyclipostinen

Info

Publication number
DE602007013772D1
DE602007013772D1 DE602007013772T DE602007013772T DE602007013772D1 DE 602007013772 D1 DE602007013772 D1 DE 602007013772D1 DE 602007013772 T DE602007013772 T DE 602007013772T DE 602007013772 T DE602007013772 T DE 602007013772T DE 602007013772 D1 DE602007013772 D1 DE 602007013772D1
Authority
DE
Germany
Prior art keywords
treatment
cyclipostins
mycobacterial infections
mycobacterial infection
mycobacteriosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007013772T
Other languages
English (en)
Inventor
Gerhard Seibert
Luigi Toti
Joachim Wink
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Publication of DE602007013772D1 publication Critical patent/DE602007013772D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602007013772T 2006-08-29 2007-08-14 Behandlung mykobakterieller infektionen mit cyclipostinen Active DE602007013772D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06017963A EP1894601A1 (de) 2006-08-29 2006-08-29 Behandlung mykobakterieller Infektionen mit Cyclipostinen
PCT/EP2007/007159 WO2008025449A1 (en) 2006-08-29 2007-08-14 Treating mycobacterial infections with cyclipostins

Publications (1)

Publication Number Publication Date
DE602007013772D1 true DE602007013772D1 (de) 2011-05-19

Family

ID=37507603

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007013772T Active DE602007013772D1 (de) 2006-08-29 2007-08-14 Behandlung mykobakterieller infektionen mit cyclipostinen

Country Status (15)

Country Link
US (1) US7923438B2 (de)
EP (2) EP1894601A1 (de)
JP (1) JP5337696B2 (de)
KR (1) KR20090045291A (de)
CN (1) CN101511431A (de)
AT (1) ATE504333T1 (de)
AU (1) AU2007291601A1 (de)
BR (1) BRPI0715758A2 (de)
CA (1) CA2661590A1 (de)
DE (1) DE602007013772D1 (de)
IL (1) IL197188A0 (de)
MX (1) MX2009001408A (de)
NO (1) NO20090927L (de)
RU (1) RU2009111262A (de)
WO (1) WO2008025449A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3349962A (en) * 1966-01-27 1967-10-31 Desoto Inc Automatic paint colorant dispensers
CN101851663A (zh) * 2009-04-01 2010-10-06 湖南省天骑医学新技术有限公司 细菌、细胞药敏检验方法及药敏检验装置
CN102010886B (zh) * 2010-06-02 2016-08-17 湖南省天骑医学新技术股份有限公司 结核分枝杆菌药敏试验方法及指示剂的应用及固体培养基
WO2013007570A1 (en) 2011-07-12 2013-01-17 Centre National De La Recherche Scientifique Method for the high-speed screening of lipase activity and/or lipase inhibitors in biological samples and in culture media
WO2015127381A1 (en) 2014-02-21 2015-08-27 The Curators Of The University Of Missouri Fluorescent labeled inhibitors
KR102462751B1 (ko) * 2021-10-20 2022-11-03 순천향대학교 산학협력단 신규한 페디오코커스 균주 및 이를 포함하는 결핵 예방, 치료, 또는 개선용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04145089A (ja) * 1990-10-05 1992-05-19 Nippon Kayaku Co Ltd 抗生物質ｎｋ９０１０９３、その製造法及びそれを有効成分として含有する殺虫・殺ダニ剤
JPH0656859A (ja) * 1991-07-25 1994-03-01 Nippon Kayaku Co Ltd 抗生物質ｎｋ９０１０９３ａ、その製造法及びそれを有効成分として含有する殺虫・殺ダニ剤
DE10021731B4 (de) 2000-05-04 2005-12-08 Aventis Pharma Deutschland Gmbh Cyclipostine, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung derselben
NO312138B1 (no) * 2000-05-04 2002-03-25 Kongsberg Offshore As Fremgangsmåte og sjöbasert installasjon for håndtering og behandling av flerfraksjonshydrokarboner til sjös
US6756402B2 (en) * 2000-05-04 2004-06-29 Aventis Pharma Deutschland Gmbh Cyclipostins, process for their preparation and use thereof
JP4145089B2 (ja) 2002-07-22 2008-09-03 ケミカルグラウト株式会社 メタンガス採取工法
DE102004046142B4 (de) 2004-09-21 2006-08-24 Hans-Knöll-Institut für Naturstoff-Forschung e.V. Neue selektiv wirksame Substanzen zur Behandlung von Krankheiten, die durch Mykobakterien hervorgerufen werden, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
BRPI0715758A2 (pt) 2013-07-16
JP2010501603A (ja) 2010-01-21
JP5337696B2 (ja) 2013-11-06
EP2059304B1 (de) 2011-04-06
AU2007291601A1 (en) 2008-03-06
ATE504333T1 (de) 2011-04-15
MX2009001408A (es) 2009-02-17
KR20090045291A (ko) 2009-05-07
CN101511431A (zh) 2009-08-19
IL197188A0 (en) 2009-12-24
WO2008025449A1 (en) 2008-03-06
US7923438B2 (en) 2011-04-12
EP2059304A1 (de) 2009-05-20
US20090233884A1 (en) 2009-09-17
RU2009111262A (ru) 2010-10-10
EP1894601A1 (de) 2008-03-05
NO20090927L (no) 2009-03-25
CA2661590A1 (en) 2008-03-06

Similar Documents

Publication Publication Date Title
NO20090927L (no) Behandling av mykobakterielle infeksjoner med cyklipostiner
CY1106958T1 (el) Ν-αλκυλο-4-μεθυλεναμινο-3-υδροξυ-2-πυριδονες ως αντιμικροβιακα
UA107591C2 (xx) Пестицидна композиція і її застосування
ME01992B (me) Jedinjenje diarilhidantoina
CY1112483T1 (el) Αγωνιστες gpcr πιπεριδινης
PA8678901A1 (es) Derivados de quinolina como agentes antibacteriales
ATE528311T1 (de) Glycomimetische inhibitoren des pa-il-lectins, pa-iil-lectins oder beider lectine aus pseudomonas
EP2639229A3 (de) Thiazolderivate und deren Verwendung als VAP-1-Hemmer
UA109557C2 (uk) Похідні 2-піперазин-1-іл-4h-1,3-бензотіазин-4-ону та їх застосування для лікування інфекцій у ссавців
ATE520651T1 (de) Substituierte phenylmethylbicyclocarbonsäureamidverbindungen
NO20052788L (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
PH12015501427A1 (en) Saturated nitrogen and n-acylated heterocycles potentiating the activity of an active antibiotic against mycobacteria
BRPI0807066A8 (pt) Combinações sinergísticas de compostos ativos fungicidas
UY30788A1 (es) Compuestos quimicos
MA32375B1 (fr) Derives de 5-hydroxymethyl-oxazolidine-2-one pour le traitement de maladies intestinales bacteriennes
EA200800151A1 (ru) Производные хинолина в качестве антибактериальных агентов
CY1119483T1 (el) Θεραπευτικος παραγων για τις αγχωδεις διαταραχες
CY1124577T1 (el) Καινοτομες ενωσεις τετραζολιου και η χρηση τους στη θεραπεια της φυματιωσης
NO20080144L (no) Spiro-benzimidazoler som inhibitorer av magesyre og sekresjon
UY29012A1 (es) "oxazolididonas y composiciones y metodos relacionados"
EA200800152A1 (ru) Производные хинолина в качестве антибактериальных агентов
CY1112684T1 (el) 3-κυανοπυρρολιδινυλ-φαινυλ-οξαζολιδινονες ως αντιβακτηριδιακα μεσα
CL2008003758A1 (es) Compuestos derivados de 1(2)h-tetrazol-5-il-fenil-oxazolidinonas, procedimiento de preparacion, composicion farmaceutica, util para el tratamiento de infecciones bacterianas.
DE602005017663D1 (de) Tetralin- und indanderivate und anwendungen davon
ATE482198T1 (de) Sitamaquintosylat zur behandlung von leishmaniase